Literature DB >> 9797728

Immunohistochemical localisation of advanced glycation end products in pulmonary fibrosis.

T Matsuse1, E Ohga, S Teramoto, M Fukayama, R Nagai, S Horiuchi, Y Ouchi.   

Abstract

AIM: To investigate the presence and distribution of advanced glycation end products (AGE) in pulmonary fibrosis.
METHODS: Lung tissue samples obtained from seven necropsy cases with idiopathic pulmonary fibrosis and seven with normal pulmonary parenchyma were examined immunohistochemically with a monoclonal antibody specific for AGE: 6D12. We also tested three cases with diffuse alveolar damage.
RESULTS: All the specimens from cases with pulmonary fibrosis and diffuse alveolar damage showed strong AGE expression on macrophages. Lung specimens from normal parenchyma showed positive AGE immunoreactivity on macrophages from only two of seven cases.
CONCLUSIONS: These findings suggest that AGE modified proteins accumulate in alveolar macrophages in patients with diffuse alveolar damage and idiopathic pulmonary fibrosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9797728      PMCID: PMC500804          DOI: 10.1136/jcp.51.7.515

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  26 in total

1.  Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.

Authors:  M Neeper; A M Schmidt; J Brett; S D Yan; F Wang; Y C Pan; K Elliston; D Stern; A Shaw
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

2.  Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging.

Authors:  N Araki; N Ueno; B Chakrabarti; Y Morino; S Horiuchi
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

Review 3.  Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.

Authors:  M Brownlee; A Cerami; H Vlassara
Journal:  N Engl J Med       Date:  1988-05-19       Impact factor: 91.245

4.  Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging.

Authors:  M Kirstein; J Brett; S Radoff; S Ogawa; D Stern; H Vlassara
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

5.  Hydroxyl radical mediates N epsilon-(carboxymethyl)lysine formation from Amadori product.

Authors:  R Nagai; K Ikeda; T Higashi; H Sano; Y Jinnouchi; T Araki; S Horiuchi
Journal:  Biochem Biophys Res Commun       Date:  1997-05-08       Impact factor: 3.575

6.  Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure.

Authors:  S Horiuchi; N Araki; Y Morino
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

Review 7.  Role of oxidative stress in development of complications in diabetes.

Authors:  J W Baynes
Journal:  Diabetes       Date:  1991-04       Impact factor: 9.461

Review 8.  Cytokines of the lung.

Authors:  J Kelley
Journal:  Am Rev Respir Dis       Date:  1990-03

9.  Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling.

Authors:  H Vlassara; M Brownlee; K R Manogue; C A Dinarello; A Pasagian
Journal:  Science       Date:  1988-06-10       Impact factor: 47.728

10.  Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors.

Authors:  H Vlassara; M Brownlee; A Cerami
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Advanced glycation: an important pathological event in diabetic and age related ocular disease.

Authors:  A W Stitt
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

Review 2.  New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis.

Authors:  Qiang Ding; Tracy Luckhardt; Louise Hecker; Yong Zhou; Gang Liu; Veena B Antony; Joao deAndrade; Victor J Thannickal
Journal:  Drugs       Date:  2011-05-28       Impact factor: 9.546

3.  Aliskiren attenuates bleomycin-induced pulmonary fibrosis in rats: focus on oxidative stress, advanced glycation end products, and matrix metalloproteinase-9.

Authors:  Sally A Abuelezz; Nevien Hendawy; Wesam M Osman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-07       Impact factor: 3.000

4.  Advanced glycation end-products and receptor for advanced glycation end-products expression in patients with idiopathic pulmonary fibrosis and NSIP.

Authors:  Sun Young Kyung; Kyung Hee Byun; Jin Young Yoon; Yu Jin Kim; Sang Pyo Lee; Jeong-Woong Park; Bong Hee Lee; Jong Sook Park; An Soo Jang; Choon Sik Park; Sung Hwan Jeong
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

5.  A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis.

Authors:  Judson M Englert; Lana E Hanford; Naftali Kaminski; Jacob M Tobolewski; Roderick J Tan; Cheryl L Fattman; Lasse Ramsgaard; Thomas J Richards; Inna Loutaev; Peter P Nawroth; Michael Kasper; Angelika Bierhaus; Tim D Oury
Journal:  Am J Pathol       Date:  2008-02-02       Impact factor: 4.307

6.  Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries.

Authors:  Evanthia Diamanti-Kandarakis; Christina Piperi; Efstratios Patsouris; Penelope Korkolopoulou; Dimitrios Panidis; Leszek Pawelczyk; Athanasios G Papavassiliou; Antoni J Duleba
Journal:  Histochem Cell Biol       Date:  2007-01-05       Impact factor: 2.531

Review 7.  Potential Biochemical Mechanisms of Lung Injury in Diabetes.

Authors:  Hong Zheng; Jinzi Wu; Zhen Jin; Liang-Jun Yan
Journal:  Aging Dis       Date:  2017-02-01       Impact factor: 6.745

Review 8.  Diabetic lung disease: fact or fiction?

Authors:  Saeed Kolahian; Veronika Leiss; Bernd Nürnberg
Journal:  Rev Endocr Metab Disord       Date:  2019-09       Impact factor: 6.514

9.  Blockade of advanced glycation end product formation attenuates bleomycin-induced pulmonary fibrosis in rats.

Authors:  Lei Chen; Tao Wang; Xun Wang; Bei-Bei Sun; Ji-Qiong Li; Dai-Shun Liu; Shang-Fu Zhang; Lin Liu; Dan Xu; Ya-Juan Chen; Fu-Qiang Wen
Journal:  Respir Res       Date:  2009-06-24

Review 10.  Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis.

Authors:  Thị Hằng Giang Phan; Panagiotis Paliogiannis; Gheyath K Nasrallah; Roberta Giordo; Ali Hussein Eid; Alessandro Giuseppe Fois; Angelo Zinellu; Arduino Aleksander Mangoni; Gianfranco Pintus
Journal:  Cell Mol Life Sci       Date:  2020-11-17       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.